Skip to main content

Closed

SPRB: Spruce Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-74.4%

Financially safe

Stretched

Debt / equity0.21×

Interest coverage-46.7×

Current ratio4.67×

Spruce Biosciences, Inc.

SPRBNASDAQ Capital Market·USD·Closed

Spruce Biosciences, Inc.

SPRBNASDAQ·USD·Closed

$42.83

−1.25%

$42.83

−$0.54 (1.25%)

52W Range

5thpctl

Volume

0.36×avg

Mkt Cap

58.76MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.36×avg

Market Cap

58.76MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings